⚠️ Depo-Provera Under Fire: What They’re Not Telling You 💊

Some women have suffered serious side effects — including radiation-like symptoms — and many have had their lives deeply affected.

In 2024, the European Union officially added a warning label linking Depo-Provera to meningioma (a type of brain tumor).
🇨🇦 Canada has recognized this risk since 2006.
🇺🇸 But in the United States, no such warning exists.

When faced with a lawsuit, Pfizer admitted it became aware of the risks of meningiomas in 2023, and even asked the FDA to update the drug’s warning label.
Pfizer claims the FDA rejected that request.

📄 The FDA, in a letter cited by Pfizer, said:

“The findings of the available observational studies alone do not support the addition of a warning.”

Meanwhile, Pfizer told NBC News that it stands behind the safety and efficacy of Depo-Provera.

So here we are — Europe warns women. Canada warns women.
But in America? Silence.

💭 Who is really being protected here — patients or profits?

#BigPharma 💰
#DepoProvera ⚕️
#HealthFreedom ✊
#MedicalTruth 🧠
https://t.me/teb_eslamii_irani/17062
✅ @rahyafte_en